Advancing Health A CASE STUDY from MedStar Washington Hospital Center

Curing Bladder Cancer: Robotic with Urinary Diversi on

Lambros Stamatakis, MD Washington Cancer Institute at MedStar Washington Hospital Center

Abstract A 73-year-old male was found to have invasive bladder cancer upon workup for blood in the urine. He underwent a robotic-assisted laparoscopic cystectomy, regional lymphadenectomy and an ileal conduit . This minimally invasive approach resulted in reduced postoperative pain, a shorter hospital stay, and a quicker return to preoperative activities for the patient. He remains cancer-free a year after the procedure. CASE STUDY Robotic Cystectomy with Urinary Diversion

Patient Presentation Treatment • 73-year-old male with intermittent • After successful completion of gross hematuria and irritative neoadjuvant chemotherapy, voiding symptoms. Dr. Stamatakis performed a robotic-assisted laparoscopic Past medical history of cystoprostatectomy, bilateral pelvic ● hypertension, hyperlipidemia and and iliac lymphadenectomy and an BPH (enlarged ). ileal conduit urinary diversion. The conduit was created by harvesting a Assessment 15cm segment of distal ileum to • Before referral to MedStar which the were connected Washington Hospital Center, the proximally, after a which an abdominal patient had a and stoma was made with the di stal end. bladder tumor resection that showed a high-grade urothelial Outcomes carcinoma, which was not invading • Patient’s postoperative course was the detrusor layer of the bladder. unremarkable, and his pain was well-controlled with oral Re-staging cystoscopy and biopsy medication. ● at our institution revealed pathologic upstaging to a muscle- Conclusion invasive tumor. A radical • Minimally invasive robotic cystectomy with urinary diversion approaches to bladder removal was recommended. can result in less postoperative The patient was seen in our pain and improved recovery with ● multidisciplinary cancer clinic and equivalent oncologic outcomes, was recommended to proceed with compared to traditional open neoadjuvant chemotherapy surgery. (gemcitabine & cisplatin) followed Bladder-sparing therapies can be by radical cystectomy and urinary ● used in non-muscle invasive diversion. bladder cancer, but in muscle- Diagnosis invasive and locally advanced •Urothelial carcinoma of the tumors, extirpation with radical bladder. cystectomy with urinary diversion is typically recommended. Radical cystectomy should also be offered to those patients with persistent/recurrent non-muscle invasive bladder cancer despite bladder-sparing therapies. “Robotic approaches to urologic malignancies are beneficial for our patients because they can reduce surgical morbidity, shorten hospital stays and return them to their pre-surgical lifestyle quicker than open surgery. Robotic bladder surgery also results in less intraoperative blood loss, thus reducing the need for perioperative blood Lambros Stamatakis, MD transfusions.”

Experts in Advanced Urologic Robotic Surgical Procedures Our multi-disciplinary approach to diagnosis and management of benign and malignant tumors of the male genitourinary and the female provides individualized treatment plans and improved outcomes for cancer patients at all stages. We are experts in minimally invasive, advanced open, laparoscopic and robotic surgery. More than 90 percent of all urologic surgeries are performed using robotic surgery, ensuring that maximum functionality is restored to affected organs aer treatment. Washington Cancer Institute at MedStar Washington Hospital Center is a state-of- the-art facility, featuring some of the most sophisticated diagnostic and treatment technologies in the country. Each year, we diagnose more than 2,300 new cases of cancer, more than any other cancer center in the Washington region. M r c c T T W 1 M c e e a o o o 1 s p n e Non- Profit e a e

d n i t 0 l s a

t Organization e d s e S a s r c r h t I l c S a u

h a , r

f U.S. Postage h

i o r r t v a l n e

t

a n r m h W i a g d

n r

PAID t o t o m r

t a u g s i W e

n MedStar Washington Hospital Center

o MedStar Washington o s p l a

o h g e i S n n t Hospital Center a t

i 110 Irving Street, NW, EB 7118 i r a t

n t , n , s e a h

l . g D p g . , h e n ,

t Washington, DC 20010 I

N

o l t i p t C 1

e h n

i n i 0 n l W e

s a g e

0 2

H

f t s m

o t a , h l 0 e o o

a s e r o 0 r s

n m e s g c p l 1 t a e

i a

H v t r a c s 0 a l g t o i t l o l

s e

i h m

D o C s i s o t t p

n p e

r s p M l . n p a e

i r S t t i x i l t e e a v

a t r v c a a d l l a

s i t i m C s s e s S i

, e i n a

e t t s n a

a . 9 n t t o t h o 2 r a t t e W 6 - e

k f

y - n o i r b o s a

a r e , - t u s

d p i a o h r , r

t n

o m i o

n

2 fi a a f t g n fi 0 j

o h d c t 2 r o

o e

a - s t

e

n 8 p m o a i . 7 t c r a o a h

j 7 l f o r

i o i n g - r n 3

r g r /

t

e 9 a U a h f n e

6 e r p r d

o n 8 r a

a a l . t l o t

i i e o g n n y ’ s t .